Totals
- Total revenue
- $646,964
- Total expenses
- $726,925
- Contributions and grants received
- $611,254
- Contributions, gifts and grants paid
- $585,579
- Fair market value of assets, end of year
- $1,008,983
Listed in Part VIII
-
Amanda H GregoryAMANDA H GREGORY
VP, DIR
- Total calculated
- $0
- Hours/week
- 1
-
Heath H GregoryHEATH H GREGORY
PRES, DIR, SEC, TREAS
- Total calculated
- $0
- Hours/week
- 1
Compensation is as filed in Part VIII of the Form 990-PF: compensation, contributions to benefit plans, expense account, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total.
Grants paid on this return
These are the grants the foundation paid during the year. The “Contributions, gifts and grants paid” total above is the figure on its books, which a foundation using accrual accounting records when it commits to a grant rather than when it pays. The two need not agree: a grant promised one year and paid in another is counted in different years.
-
CITY OF HOPE
$50,000
DUARTE, CA
TARGETING NON-CODING RNA PSEUDOURIDINE MODIFICATION FOR GLIOBLASTOMA THERAPY
-
CORNELL UNIVERSITY
$50,000
ITHACA, NY
TO FUND PROJECT "REGULATION OF MYELOID CELLS BY FATTY ACID METABOLISM IN IRRADIATED GLIOBLASTOMA." 2ND YEAR RENEWAL
-
DUKE UNIVERSITY
$50,000
DURHAM, NC
SIRPIGLENASTAT FOR TREATING GLIOBLASTOMA
-
REGENTS UNIVERSITY OF CALIFORNIA LOS ANGELES
$50,000
LOS ANGELES, CA
CHARACTERIZING PTPRZ1 MECHANISM IN CANCER AS A THERAPEUTIC TARGET, 3RD YEAR FUNDING
-
THE UCLA FOUNDATION
$50,000
LOS ANGELES, CA
HAPTEN-MODIFIED NEOANTIGENS AS IMMUNE TARGETS FOR GLIOBLASTOMA TREATMENT
-
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
$50,000
HOUSTON, TX
PROJECT FP00009152 - REPURPOSING MIGRAINE TREATMENTS FOR DIPG - 5TH YEAR FUNDING
-
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
$50,000
HOUSTON, TX
AUTOPHAGY INHIBITION TO SENSITIZE MEDULLOBLASTOMA TO ENHANCE NK CELL IMMUNOTHERAPY
-
UNIVERSITY OF ALABAMA AT BIRMINGHAM
$50,000
BIRMINGHAM, AL
TARGETING RECURRENT GLIOBLASTOMA CELLS USING COLLAGEN-BINDING IL-12 AND IL-7
-
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
$50,000
SAN FRANCISCO, CA
DEFINING NEURAL DEPENDENT VULNERABILITIES IN GBM RADIATION SENSITIZATION USING FUNCTIONAL GENOMICS
-
UNIVERSITY OF SOUTHERN CALIFORNIA
$50,000
LOS ANGELES, CA
THE ROLE OF GABA TRANSAMINASE IN MEDULLOBLASTOMA LOCAL RECURRENCE AND ITS POTENTIAL AS A THERAPEUTIC TARGET IN MEDULLOBLASTOMA METASTASIS 3RD YEAR FUNDING
The 10 largest to organizations. The API serves every grant row.
Provenance
- Return type
- form_990_pf
- Tax year
- 2025
- Filed
- 24 July 2026
- IRS schema version
- 2025v4.2
- Source object
- 202612099349100111
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.